A this PHA live webinar speakers Sandeep Sahay, and Vallerie V. McLaughlin discussed hopeful discoveries from late-stage clinical trials and the differences between current symptom management practices and new disease-modifying therapeutics. The webinar will be moderated by PHA’s Elizabeth Joseloff.
This webinar covered the following topics:
• The differences between the current symptom management practices and new therapeutics in the pipeline.
• The potential impact of treatments on future patient outcomes.
• New pathways to target pulmonary arterial hypertension.
• Promising discoveries in late-stage clinical trials.
We expect that the recording will be available shortly, we will share as soon as it is made public.
